ACQUIRED · 2019
Who Acquired Accent (Intrado)?
HMS Holdings Corp. · $155.0M· 10.5× EBITDA
The acquisition
Accent (Intrado) was acquired by HMS Holdings Corp. in 2019 for $155.0M. The deal was priced at 10.5× EBITDA / 3.10× revenue.
Accent (Intrado) at time of acquisition
Revenue
$50.0M
EBITDA
$14.7M
Deal value
$155.0M
EV / EBITDA
10.5×
Similar healthcare it acquisitions
- Eucalyptus · acquired by Hims & Hers Health, Inc. in 2026 · $1.15B
- Gleamer SAS · acquired by RadNet, Inc. in 2026 · $251.6M
- HealthEZ · acquired by Blue Cross Blue Shield of New Jersey in 2026 · $360.0M
- Unbound Medicine · acquired by MPS Ltd in 2026 · $16.5M
- AccessOne · acquired by Phreesia, Inc. in 2025 · $160.0M
Run a valuation for a similar healthcare it business
Three fields, instant range, backed by 25,592 real M&A transactions including this one.
Open the healthcare it calculator →More on healthcare it valuations
- Healthcare It valuation calculator· head-term variant
- Healthcare It median multiples· real-deal benchmarks
- How to value a healthcare it· long-form guide
Sourced from Press releases. Full deal page.
Citation: ExitValue.ai. (2019). Accent (Intrado) acquired by HMS Holdings Corp.. https://exitvalue.ai/acquired/accent-intrado